GlassScriptPhysician profile
Floyd B Russak
NPI 1902898984
$17,728.84
in general payments reported to CMS, 2019-2025
56 companies · $2,656 in 2025
The $2,656 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,645 · 2020: $1,695 · 2021: $4,015 · 2022: $2,242 · 2023: $2,751 · 2024: $2,725 · 2025: $2,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,131.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $3,692.57 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $2,039.80 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,655.28 | 2020-2025 | Vraylar, Ubrelvy, Qulipta |
| Novartis Pharmaceuticals Corporation | $1,283.60 | 2019-2025 | |
| Esperion Therapeutics, INC. | $927.89 | 2020-2025 | Nexletol |
| Novo Nordisk INC | $878.53 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $605.38 | 2020-2025 | Mounjaro, Zepbound, Kisunla |
| Heartflow, INC. | $542.62 | 2024-2025 | |
| Eisai INC. | $481.26 | 2020-2021 | |
| Allergan, INC. | $450.43 | 2019-2020 | |
| Glaxosmithkline, LLC. | $412.25 | 2020-2024 | Trelegy Ellipta, Arexvy |
| Amarin Pharma, INC. | $319.29 | 2019-2024 | |
| Alkermes, INC. | $309.22 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $302.37 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $298.65 | 2022-2025 |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floyd Russak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.